Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy

Helicobacter

Volumn 6, Issue 1, 2001, Pages 66-76

  Griffiths, Robert I ^a,j   Rabeneck, Linda ^b   Guzman, Gladys ⁱ   Cromwell, David M ^c   Strauss, Michael J ^d   Robinson, John W ^h   Winston, Bradley ^e   Li, Theodore ^g   Graham, David Y ^f  

^a Proj HOPE Center for Health Affairs   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f Department of Genetic and Molecular Toxicology   (United States)

^g St Mark's Health Care Foundation   (United States)

^h KAISER PERMANENTE   (United States)

ⁱ Spring Valley Primary Care   (United States)

^j MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH SALICYLATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR; TETRACYCLINE; UREASE;

ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DRUG COST; ENDOSCOPY; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

BREATH TESTS; COHORT STUDIES; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MODELS, THEORETICAL; PEPTIC ULCER; UREASE;

HELICOBACTER PYLORI; NEGIBACTERIA; TRIXIS;

EID: 0034958187     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2001.00008.x     Document Type: Article

References (25)

1. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer
2. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
3. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials
4. Helicobacter pylori in peptic ulcer disease
5. A cost analysis of alternative treatments for duodenal ulcer
6. Costs of duodenal ulcer therapy with antibiotics
7. Diagnosis and eradication of Helicobacter pylori in the management of peptic ulcer disease: A decision analysis model
8. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada
9. The cost-effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden
10. Eradication of Helicobacter pylori with clarithromycin and omeprazole
11. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori
12. Helicobacter pylori
13. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection
14. Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis
15. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
16. Alternative management strategies for patients with suspected peptic ulcer disease
17. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients
18. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: A prospective study
19. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy
20. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated
21. Non-invasive detection of Helicobacter pylori in clinical practice: The 13 C urea breath test